Comparison of Peri-intubation Oxygenation Values and Complications in Patients Intubated With the Delayed Versus Rapid Sequence Intubation Protocols

Condition(s) studied

Investigational drug(s) / intervention(s)

Delayed Sequence Intubation: Patients assigned to the Delayed Sequence Intubation (DSI) protocol will receive an initial dose of 1 mg/kg ketamine. Titrated additional doses of 0.5 mg/kg will be administered until 'adequate sedation/dissociation' is achieved, ensuring the preservation of airway reflexes and spontaneous respiration. Subsequently, 'preoxygenation' will be performed for 3 minutes with 'appropriate positioning,' using a non-rebreather mask or bag-valve-mask combined with a nasal cannula delivering maximum oxygen flow (10-15 L/min). Following the induction of paralysis with an intravenous push of rocuronium (1 mg/kg), endotracheal intubation will be performed using direct laryngoscopy. Throughout the protocol, relevant physiological parameters will be recorded on the study data form by a designated physician.

Rapid Sequence Intubation: Patients assigned to the Rapid Sequence Intubation (RSI) protocol will receive 'preoxygenation' for 3 minutes using a non-rebreather mask (NRM) or bag-valve-mask (BVM) combined with a nasal cannula delivering maximum oxygen flow (10-15 L/min), following the necessary preparation period. Subsequently, appropriate sedation and paralysis will be achieved through the sequential administration of intravenous (IV) ketamine (1 mg/kg push) and rocuronium (1 mg/kg IV push). Following induction, endotracheal intubation will be performed via direct laryngoscopy. Throughout the protocol, relevant physiological parameters will be recorded on the study data form by a designated physician

Study summary

This study compares two different methods of helping patients breathe by placing a tube in their airway (intubation) in an emergency setting. These methods are called Rapid Sequence Intubation (RSI) and Delayed Sequence Intubation (DSI).

The study focuses on adult patients who are still breathing on their own but need a breathing tube for medical reasons not related to an injury (non-trauma).

The main goal of the research is to compare:

* Oxygen levels before and after the procedure.
* The patient's vital signs (such as heart rate and blood pressure).
* The number of attempts needed to successfully place the tube and the time the procedure takes.
* Blood gas results and any complications that occur during or shortly after the procedure.
* Early survival (mortality) rates.

While there are previous studies on trauma patients or small observational reports, there is currently no large-scale, multicenter randomized controlled trial that includes all non-trauma adult patients.

What makes this study unique? Confirmation of Tube Placement: Researchers will use a specific measurement called end-tidal CO2 (etCO2) to confirm the tube is in the right place, a method not used in similar previous studies.

Assessing Difficulty: This study will use the Cormack-Lehane classification system to measure how difficult the intubation was for each patient.

Standardization: For the first time, breathing machine (ventilator) settings will be standardized for all patients in this type of study.

Real-World Practice: By involving all emergency department physicians as practitioners, the study aims to show how these methods work across a wide range of medical teams.

Eligibility

Primary outcome measure(s)

• Number of Participants with Procedure-Related Adverse Events — During and 1 hours after intubation
  Hypoxia(Spo2\<90), hypotension (systolic blood pressure \<90mmHg or blood pressure drop \>20mmg after intiation of intubation protocol), orogastric intubation, cardiac arrest, orolaryngeal trauma, aspiration of orogastric fluid is accepted as procedure-related adverse events
• Mean Peripheral Oxygen Saturation (SpO2) — Hospital admission, Intubation decision, Protocol start (0 min), Minutes 1, 2, 3 of protocol, During blade insertion, 1 minute post-intubation, and 5 minutes post-intubation
  Spo2 levels at admission, when intubation decision made, Spo2 level upon commencement of the intubation protocol(0-min); Spo2 level at 1st minute, 2nd minute, 3rd minute of intubation protocol, during blade passes incisor teeth, 1 minutes after intubation, 5 minutes after intubation wil be recorded
• Mean Arterial Blood pH Levels — Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.
  Evaluation of acid-base status.
• Mean Partial Pressure of Carbon Dioxide (PaCO2) — Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.
  Measure of carbon dioxide in arterial blood.
• Mean Arterial Bicarbonate (HCO3) Concentration — Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.
  Measure of bicarbonate in arterial blood.
• Mean Base Excess (BE) Levels — Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.
  Measure of base excess in arterial blood.
• Mean Arterial Lactate Concentration — Hospital admission, At the time of intubation decision, and 15 minutes post-intubation.
  Measure of lactate in arterial blood.
• First Hour Mortality — 1 hour later intubation
  Death from any cause within 60 minutes following the intubation attempt.
• 28th day mortality — 28 days after intubation
  All-cause mortality recorded during the first 28 days after enrollment.

Trial sites (4)

More Kanuni Sultan Suleyman Training and Research Hospital trials in Turkey

Other trials for the same condition